Key Metrics of Vertex Pharmaceuticals
Revenue$9.9B▲ 10.5% YoYFY 2023
Operating income$3.8B▼ 11.0% YoY
Net profit$3.6B▲ 9.0% YoY
Shareholders' equity$17.6B
Market cap$136BVRTX · $535.17
Competitors10identified
Open jobs4
About Vertex Pharmaceuticals
Part of Vertex Pharmaceuticals.
Sectors
Company details
- Website
- vrtx.com
- Founded
- 1991
- Listed
- Nasdaq: VRTX (since 1991)
Operational Areas of Vertex Pharmaceuticals
Pharmaceuticals & Healthcare›Biotechnology & Vaccines
Company summary
Legal nameVertex Pharmaceuticals Incorporated
TickerVRTX
ExchangeNasdaq
CountryUnited States
SEC CIK0000875320
Listed since1991
IndustryBiotechnology: Pharmaceutical Preparations
SectorPharmaceuticals & Healthcare · Biotechnology & Vaccines
Websitehttps://www.vrtx.com
US market & SEC filings
VRTX · Nasdaq · SEC CIK 0000875320
Last price · 25 Oct 2026
$535.17
+2.03%
Market cap$136B
P/E38.5On FY 2023 diluted EPS
Volume1,641,615
SectorHealth CareBiotechnology: Pharmaceutical Preparations
Country · IPOUnited StatesListed 1991
VRTX share price
Premium
Annual results (SEC EDGAR)
Revenue, operating income, net income, EPS, cash flow, assets, liabilities, equity and debt for every year filed with the SEC are part of the premium plan.
Sign in to continue See plans & pricingVendor checks & payment capacity
Sign in with access to company financials to review vendor evidence.
Registered office and contact
Registered officeBoston
GSTIN—
Email—
Websitehttps://www.vrtx.com
Members / shareholders—
Directors and key people
Directors are read from the MGT-7 annual return and AOC-4 signatories.
Competitors of Vertex Pharmaceuticals
Competitors10identified
Countries1most in United States
Top competitors by location
| Company | Description | Domain | Founded | Location |
|---|---|---|---|---|
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | modernatx.com | 2018 | United States | |
 Becton Dickinson |
Biotechnology & Vaccines · Pharmaceuticals & Healthcare | bd.com | — | United States |
| Part of Illumina. | illumina.com | 2000 | United States | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | guardanthealth.com | 2018 | United States | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | revvity.com | — | United States | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | exelixis.com | 2000 | United States | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | neurocrine.com | 1996 | United States | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | biomarin.com | 1999 | United States | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | bio-rad.com | 1980 | United States | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | 10xgenomics.com | 2019 | United States |
Similar companies
K
Kbk Biotech Private LimitedPharmaceuticals & Healthcare
Same segment: Biotechnology & Vaccines
C
Concord Biotech LimitedPharmaceuticals & Healthcare
Same segment: Biotechnology & Vaccines
I
International Biotech Park LimitedPharmaceuticals & Healthcare
Same segment: Biotechnology & Vaccines
B
Bharat Immunologicals And Biologicals Corporation LimitedPharmaceuticals & Healthcare
Same segment: Biotechnology & Vaccines
A
Anthem Biosciences (India)Pharmaceuticals & Healthcare
Same segment: Biotechnology & Vaccines
H
Hester Biosciences LimitedPharmaceuticals & Healthcare
Same segment: Biotechnology & Vaccines
M
Medicamen Biotech LimitedPharmaceuticals & Healthcare
Same segment: Biotechnology & Vaccines
C
CannamedicalPharmaceuticals & Healthcare
Same segment: Biotechnology & Vaccines
Charges (secured borrowings)
0 registered charges. Lenders, amounts and dates are part of the premium plan.
Statutory auditors
Auditors are read from the AOC-4 auditor's report section.
Group companies
Part of Vertex Pharmaceuticals
Business activities and related parties
pharmaceutical industry, biotechnology industry, health care industry
Filings
No filings on record yet.